4521 Kaken Pharmaceutical
- 3889.0
- +25.0+0.65%
Kaken Pharmaceutical News
Kaken Pharmaceutical: Interim report
Kaken Pharmaceutical: Confirmatory letter.
Kaken Pharmaceutical: Securities Report - 104th term (April 1, 2023 - March 31, 2024)
Kaken Pharmaceutical: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Scientific Research Pharmaceutical: Confirmation Letter
Scientific Research & Pharmaceutical: Quarterly Report - 104th Term 3rd Quarter (2023/10/01 - 2023/12/31)
Kaken Pharmaceutical: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Kaken Pharmaceutical: Confirmation letter
Kaken Pharmaceutical: Quarterly Report - 104th Second Quarter (2023/07/01 - 2023/09/30)
Kaken Pharmaceutical: Summary of Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Kaken Pharmaceutical: Confirmation letter
Kaken Pharmaceutical: Quarterly Report - 104th Quarter 1st Quarter (2023/04/01 - 2023/06/30)
Kaken Pharmaceutical: Summary of Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Kaken Pharmaceutical: Extraordinary Report
Kaken Pharmaceutical: Confirmation letter
Kaken Pharmaceutical: Securities Report - 103rd Period (2022/04/01 - 2023/03/31)
Kaken Pharmaceutical: Summary of Financial Results for the Fiscal Year Ending March 31, 2023 [Japanese GAAP] (Consolidated)
Kaken Pharmaceutical: Notice regarding differences in individual business results from the previous fiscal year
Kaken Pharmaceutical: Quarterly report-103rd quarter (2022-10-01-2022-12-31)
Kaken Pharmaceutical: Confirmation letter
Analysis
Price Target
No Data
